Showing results (181-190 of 190) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 190 results.
The Biochemical Journal|January 23, 1999
Role of phosphatidylinositol 3,4,5-trisphosphate in regulating the activity and localization of 3-phosphoinositide-dependent protein kinase-1R A Currie, K S Walker, A Gray, et al.
Cancer Investigation|June 19, 2001
Gemcitabine in the second-line therapy of patients with carcinoma of unknown primary site: a phase II trial of the Minnie Pearl Cancer Research NetworkJ D Hainsworth, H A Burris, S W Calvert, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|April 13, 2010
A high-density ERP study reveals latency, amplitude, and topographical differences in multiple sclerosis patients versus controlsR Whelan, R Lonergan, H Kiiski, et al.
The New Microbiologica|January 1, 1996
An epidemiological study on viral infantile diarrhoea in TiranaE Diamanti, F Superti, A Tinari, et al.
Acta Crystallographica. Section D, Biological Crystallography|April 26, 2001
Overexpression, purification, crystallization and data collection of 3-methylaspartase from Clostridium tetanomorphumM Asuncion, J N Barlow, J Pollard, et al.
Oncogene|November 17, 2009
Suppression of cellular proliferation and invasion by the concerted lipid and protein phosphatase activities of PTENL Davidson, H Maccario, N M Perera, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 1998
The lipid phosphatase activity of PTEN is critical for its tumor supressor functionM P Myers, I Pass, I H Batty, et al.
The Biochemical Journal|February 1, 1988
The purification and properties of myo-inositol monophosphatase from bovine brainN S Gee, C I Ragan, K J Watling, et al.
Revue Medicale Suisse|June 20, 2014
[The Onco-hematology clinical research unit at the Geneva University Hospital: example of a fruitful public-private partners]M Ackermann-Zare, V Ancrenaz, N Blazek, et al.
Journal of the Neurological Sciences|April 5, 2011
Change in PASAT performance correlates with change in P3 ERP amplitude over a 12-month period in multiple sclerosis patientsH Kiiski, R B Reilly, R Lonergan, et al.
Pageof 19